These	O	DET	O
findings	O	NOUN	B
should	O	AUX	O
be	O	AUX	O
useful	O	ADJ	O
for	O	ADP	O
therapeutic	O	ADJ	B
strategies	O	NOUN	I
and	O	CCONJ	O
the	O	DET	O
development	O	NOUN	B
of	O	ADP	O
immunosuppressants	O	NOUN	B
targeting	O	VERB	B
the	O	DET	O
CD28	B-protein	NOUN	B
costimulatory	O	ADJ	I
pathway	O	NOUN	I
.	O	PUNCT	O


Whereas	O	SCONJ	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
HIV-1	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	I
following	O	VERB	O
T-cell	O	NOUN	B
stimulation	O	NOUN	I
is	O	AUX	O
mediated	O	VERB	O
largely	O	ADV	O
through	O	ADP	O
binding	O	NOUN	B
of	O	ADP	O
the	O	DET	O
transcription	B-protein	NOUN	B
factor	I-protein	NOUN	I
NF-kappa	B-protein	NOUN	I
B	I-protein	NOUN	I
to	O	PART	O
two	O	NUM	O
adjacent	O	ADJ	B
kappa	B-DNA	NOUN	O
B	I-DNA	NOUN	O
sites	I-DNA	NOUN	O
in	O	ADP	O
the	O	DET	O
HIV-1	B-DNA	NOUN	B
long	I-DNA	ADJ	B
terminal	I-DNA	ADJ	I
repeat	I-DNA	NOUN	I
,	O	PUNCT	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
HIV-2	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	I
in	O	ADP	O
monocytes	B-cell_type	NOUN	B
and	O	CCONJ	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
is	O	AUX	O
dependent	O	ADJ	O
on	O	ADP	O
four	O	NUM	O
cis-acting	B-DNA	ADJ	B
elements	I-DNA	NOUN	I
:	O	PUNCT	O
a	O	DET	O
single	O	ADJ	B
kappa	B-DNA	NOUN	I
B	I-DNA	NOUN	I
site	I-DNA	NOUN	I
,	O	PUNCT	O
two	O	NUM	O
purine-rich	B-DNA	ADJ	B
binding	I-DNA	VERB	I
sites	I-DNA	NOUN	I
,	O	PUNCT	O
PuB1	B-DNA	NOUN	B
and	O	CCONJ	O
PuB2	B-DNA	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
pets	B-DNA	NOUN	B
site	I-DNA	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
now	O	ADV	O
identified	O	VERB	B
a	O	DET	O
novel	O	ADJ	O
cis-acting	B-DNA	ADJ	B
element	I-DNA	NOUN	I
within	O	ADP	O
the	O	DET	O
HIV-2	B-DNA	NOUN	B
enhancer	I-DNA	NOUN	I
,	O	PUNCT	O
immediately	O	ADV	O
upstream	O	ADJ	B
of	O	ADP	O
the	O	DET	O
kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
site	I-DNA	NOUN	I
,	O	PUNCT	O
designated	O	VERB	O
peri-kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
.	O	PUNCT	O


Understanding	O	VERB	O
the	O	DET	O
monocyte-specific	O	ADJ	B
function	O	NOUN	I
of	O	ADP	O
the	O	DET	O
peri-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
factor	I-protein	NOUN	I
may	O	AUX	O
ultimately	O	ADV	O
provide	O	VERB	O
insight	O	NOUN	O
into	O	ADP	O
the	O	DET	O
different	O	ADJ	O
role	O	NOUN	O
monocytes	B-cell_type	NOUN	B
and	O	CCONJ	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
play	O	VERB	O
in	O	ADP	O
HIV	O	NOUN	B
pathogenesis	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
inability	O	NOUN	B
of	O	ADP	O
E1A	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
products	O	NOUN	I
to	O	PART	O
induce	O	VERB	B
cytolytic	O	ADJ	B
susceptibility	O	NOUN	I
during	O	ADP	O
infection	O	NOUN	B
was	O	AUX	O
not	O	PART	O
explained	O	VERB	O
by	O	ADP	O
an	O	DET	O
inhibitory	O	ADJ	B
effect	O	NOUN	O
of	O	ADP	O
viral	O	ADJ	B
infection	O	NOUN	I
on	O	ADP	O
otherwise	O	ADV	O
susceptible	O	ADJ	B
target	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
or	O	CCONJ	O
by	O	ADP	O
viral	B-DNA	ADJ	B
gene	I-DNA	NOUN	I
effects	O	NOUN	O
on	O	ADP	O
class	B-protein	NOUN	B
I	I-protein	NUM	I
MHC	I-protein	NOUN	I
antigen	I-protein	NOUN	I
expression	O	NOUN	B
on	O	ADP	O
target	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


This	O	DET	O
differential	O	ADJ	B
effect	O	NOUN	I
of	O	ADP	O
E1A	B-protein	NOUN	B
expression	O	NOUN	B
on	O	ADP	O
the	O	DET	O
cytolytic	O	ADJ	B
phenotypes	O	NOUN	B
of	O	ADP	O
infected	O	ADJ	B
and	O	CCONJ	O
stably	O	ADV	B
transfected	O	VERB	B
human	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
suggests	O	VERB	O
that	O	SCONJ	O
human	B-cell_type	ADJ	B
NK	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
provide	O	VERB	O
an	O	DET	O
effective	O	ADJ	B
immunologic	O	ADJ	B
barrier	O	NOUN	I
against	O	ADP	O
the	O	DET	O
in	O	X	B
vivo	O	X	I
survival	O	NOUN	B
and	O	CCONJ	O
neoplastic	O	ADJ	B
progression	O	NOUN	B
of	O	ADP	O
E1A-immortalized	B-cell_line	ADJ	B
cells	I-cell_line	NOUN	I
that	O	PRON	O
may	O	AUX	O
emerge	O	VERB	O
from	O	ADP	O
the	O	DET	O
reservoir	O	NOUN	B
of	O	ADP	O
persistently	B-cell_type	ADV	B
infected	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	B
in	O	ADP	O
the	O	DET	O
human	O	ADJ	B
host	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
CD4	B-protein	NOUN	B
coreceptor	I-protein	NOUN	I
interacts	O	VERB	O
with	O	ADP	O
non-polymorphic	B-protein	ADJ	B
regions	I-protein	NOUN	I
of	O	ADP	O
major	B-protein	ADJ	O
histocompatibility	I-protein	NOUN	O
complex	I-protein	NOUN	O
class	I-protein	NOUN	O
II	I-protein	NUM	O
molecules	I-protein	NOUN	O
on	O	ADP	O
antigen-presenting	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
contributes	O	VERB	O
to	O	PART	O
T	O	NOUN	B
cell	O	NOUN	I
activation	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
investigated	O	VERB	B
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
CD4	B-protein	NOUN	B
triggering	O	NOUN	B
on	O	ADP	O
T	O	NOUN	B
cell	O	NOUN	I
activating	O	NOUN	O
signals	O	NOUN	B
in	O	ADP	O
a	O	DET	O
lymphoma	O	NOUN	B
model	O	NOUN	I
using	O	VERB	O
monoclonal	B-protein	ADJ	B
antibodies	I-protein	NOUN	I
(	O	PUNCT	O
mAb	B-protein	NOUN	B
)	O	PUNCT	O
which	O	DET	O
recognize	O	VERB	O
different	O	ADJ	O
CD4	B-protein	NOUN	B
epitopes	I-protein	NOUN	B
.	O	PUNCT	O


Whereas	O	SCONJ	O
different	O	ADJ	O
anti-CD4	B-protein	ADJ	B
mAb	I-protein	NOUN	B
or	O	CCONJ	O
HIV-1	B-protein	NOUN	B
gp120	I-protein	NOUN	B
could	O	AUX	O
all	O	DET	O
trigger	O	VERB	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
protein	B-protein	NOUN	B
tyrosine	I-protein	NOUN	I
kinases	I-protein	NOUN	I
p56lck	B-protein	NOUN	I
and	O	CCONJ	O
p59fyn	B-protein	NOUN	B
and	O	CCONJ	O
phosphorylation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Shc	B-protein	NOUN	B
adaptor	I-protein	NOUN	I
protein	I-protein	NOUN	I
,	O	PUNCT	O
which	O	DET	O
mediates	O	VERB	O
signals	O	NOUN	B
to	O	PART	O
Ras	B-protein	NOUN	B
,	O	PUNCT	O
they	O	PRON	O
differed	O	VERB	O
significantly	O	ADV	O
in	O	ADP	O
their	O	PRON	O
ability	O	NOUN	O
to	O	PART	O
activate	O	VERB	B
NF-AT	B-protein	NOUN	B
.	O	PUNCT	O


The	O	DET	O
results	O	NOUN	B
identify	O	VERB	O
functionally	O	ADV	O
distinct	O	ADJ	O
epitopes	B-protein	NOUN	B
on	O	ADP	O
the	O	DET	O
CD4	B-protein	NOUN	B
coreceptor	I-protein	NOUN	I
involved	O	VERB	O
in	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
Ras/protein	B-protein	NOUN	B
kinase	I-protein	NOUN	I
C	I-protein	NOUN	I
and	O	CCONJ	O
calcium	O	NOUN	B
pathways	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
transcriptional	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
GATA-1	B-protein	NOUN	B
is	O	AUX	O
strongly	O	ADV	O
repressed	O	VERB	B
by	O	ADP	O
the	O	DET	O
estrogen	B-protein	NOUN	B
receptor	I-protein	NOUN	I
(	O	PUNCT	O
ER	B-protein	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
a	O	DET	O
ligand-dependent	O	ADJ	B
manner	O	NOUN	O
and	O	CCONJ	O
that	O	SCONJ	O
this	O	DET	O
repression	O	NOUN	B
is	O	AUX	O
reversible	O	ADJ	O
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
4-hydroxytamoxifen	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
coimmunoprecipitation	O	NOUN	B
experiments	O	NOUN	I
using	O	VERB	O
transfected	O	VERB	B
COS	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
GATA-1	B-protein	NOUN	B
and	O	CCONJ	O
ER	B-protein	NOUN	B
associate	O	VERB	O
in	O	ADP	O
a	O	DET	O
ligand-dependent	O	ADJ	B
manner	O	NOUN	O
.	O	PUNCT	O


We	O	PRON	O
speculate	O	VERB	O
that	O	SCONJ	O
estrogens	O	NOUN	B
exert	O	VERB	O
effects	O	NOUN	B
on	O	ADP	O
erythropoiesis	O	NOUN	B
by	O	ADP	O
modulating	O	VERB	O
GATA-1	B-protein	NOUN	B
activity	O	NOUN	B
through	O	ADP	O
protein-protein	O	ADJ	B
interaction	O	NOUN	I
with	O	ADP	O
the	O	DET	O
ER	B-protein	NOUN	B
.	O	PUNCT	O


Mouse	B-DNA	NOUN	B
interleukin-2	I-DNA	NOUN	B
receptor	I-DNA	NOUN	I
alpha	I-DNA	NOUN	I
gene	I-DNA	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


Interleukin-1	B-protein	NOUN	B
and	O	CCONJ	O
interleukin-2	B-protein	NOUN	B
control	O	VERB	O
transcription	O	NOUN	O
via	O	ADP	O
distinct	O	ADJ	O
cis-acting	B-DNA	ADJ	B
elements	I-DNA	NOUN	I
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
map	O	VERB	B
the	O	DET	O
cis-acting	B-DNA	ADJ	B
elements	I-DNA	NOUN	I
that	O	PRON	O
mediate	O	VERB	O
interleukin	O	NOUN	B
responsiveness	O	NOUN	I
of	O	ADP	O
the	O	DET	O
mouse	B-DNA	NOUN	B
IL-2R	I-DNA	NOUN	B
alpha	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
using	O	VERB	O
a	O	DET	O
thymic	B-cell_line	ADJ	B
lymphoma-derived	I-cell_line	ADJ	I
hybridoma	I-cell_line	NOUN	I
(	O	PUNCT	O
PC60	B-cell_line	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


IL-1	B-protein	NOUN	B
induces	O	VERB	B
a	O	DET	O
rapid	O	ADJ	B
,	O	PUNCT	O
protein	O	NOUN	B
synthesis-independent	O	ADJ	B
appearance	O	NOUN	B
of	O	ADP	O
IL-2R	B-RNA	NOUN	B
alpha	I-RNA	NOUN	O
mRNA	I-RNA	NOUN	B
that	O	PRON	O
is	O	AUX	O
blocked	O	VERB	B
by	O	ADP	O
inhibitors	O	NOUN	B
of	O	ADP	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
activation	O	NOUN	B
.	O	PUNCT	O


Transient	O	ADJ	B
transfection	O	NOUN	O
experiments	O	NOUN	O
show	O	VERB	O
that	O	SCONJ	O
several	O	ADJ	O
elements	O	NOUN	B
in	O	ADP	O
the	O	DET	O
promoter-proximal	B-DNA	ADJ	B
region	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
IL-2R	B-DNA	NOUN	B
alpha	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
contribute	O	VERB	O
to	O	PART	O
IL-1	B-protein	NOUN	B
responsiveness	O	NOUN	B
,	O	PUNCT	O
most	O	ADV	O
importantly	O	ADV	O
an	O	DET	O
NF-kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
site	I-DNA	NOUN	I
conserved	O	VERB	O
in	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
and	I-DNA	CCONJ	O
mouse	I-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


This	O	DET	O
segment	O	NOUN	B
functions	O	VERB	B
as	O	ADP	O
an	O	DET	O
IL-2-inducible	B-DNA	ADJ	B
enhancer	I-DNA	NOUN	I
and	O	CCONJ	O
lies	O	VERB	O
within	O	ADP	O
a	O	DET	O
region	O	NOUN	B
that	O	PRON	O
becomes	O	VERB	O
DNase	B-protein	NOUN	B
I	I-protein	NUM	I
hypersensitive	O	ADJ	B
in	O	ADP	O
normal	O	ADJ	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
in	O	ADP	O
which	O	DET	O
IL-2R	B-protein	NOUN	B
alpha	I-protein	NOUN	O
expression	O	NOUN	B
has	O	AUX	O
been	O	AUX	O
induced	O	VERB	B
.	O	PUNCT	O


This	O	DET	O
review	O	NOUN	B
focuses	O	VERB	O
on	O	ADP	O
the	O	DET	O
roles	O	NOUN	O
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
in	O	ADP	O
hematopoietic	O	ADJ	B
lineage	O	NOUN	I
commitment	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
brief	O	ADJ	O
introduction	O	NOUN	O
to	O	PART	O
lineage	O	NOUN	B
commitment	O	NOUN	B
and	O	CCONJ	O
asymmetric	O	ADJ	B
cell	O	NOUN	I
division	O	NOUN	I
is	O	AUX	O
followed	O	VERB	O
by	O	ADP	O
a	O	DET	O
discussion	O	NOUN	B
of	O	ADP	O
several	O	ADJ	O
methods	O	NOUN	B
used	O	VERB	O
to	O	PART	O
identify	O	VERB	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
important	O	ADJ	O
in	O	ADP	O
specifying	O	VERB	O
hematopoietic	B-cell_type	ADJ	B
cell	I-cell_type	NOUN	I
types	I-cell_type	NOUN	I
.	O	PUNCT	O


Next	O	ADV	O
is	O	AUX	O
presented	O	VERB	O
a	O	DET	O
discussion	O	NOUN	B
of	O	ADP	O
the	O	DET	O
use	O	NOUN	O
of	O	ADP	O
embryonic	B-cell_type	ADJ	B
stem	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
in	O	ADP	O
the	O	DET	O
analysis	O	NOUN	B
of	O	ADP	O
hematopoietic	B-DNA	ADJ	B
gene	I-DNA	NOUN	I
expression	O	NOUN	O
and	O	CCONJ	O
the	O	DET	O
use	O	NOUN	O
of	O	ADP	O
targeted	O	VERB	B
gene	O	NOUN	B
disruption	O	NOUN	B
to	O	PART	O
analyze	O	VERB	B
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
in	O	ADP	O
hematopoiesis	O	NOUN	B
.	O	PUNCT	O


Epstein-Barr	O	ADJ	B
virus	O	NOUN	I
(	O	PUNCT	O
EBV	O	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
known	O	VERB	O
to	O	PART	O
infect	O	VERB	B
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
epithelial	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


This	O	DET	O
is	O	AUX	O
in	O	ADP	O
contrast	O	NOUN	O
to	O	PART	O
the	O	DET	O
infection	O	NOUN	B
in	O	ADP	O
B	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
where	O	SCONJ	O
the	O	DET	O
genome	O	NOUN	B
can	O	AUX	O
circularize	O	VERB	B
within	O	ADP	O
24	O	NUM	O
hr	O	NOUN	O
of	O	ADP	O
infection	O	NOUN	B
.	O	PUNCT	O


ZEBRA	B-protein	NOUN	B
protein	I-protein	NOUN	I
was	O	AUX	O
also	O	ADV	O
identified	O	VERB	B
in	O	ADP	O
infected	O	ADJ	B
thymocytes	B-cell_type	NOUN	B
by	O	ADP	O
immunoprecipitation	O	NOUN	B
.	O	PUNCT	O


Transcripts	O	NOUN	B
encoding	O	VERB	B
gp350/220	B-protein	NOUN	B
,	O	PUNCT	O
the	O	DET	O
major	B-protein	ADJ	O
coat	I-protein	NOUN	B
protein	I-protein	NOUN	I
of	O	ADP	O
EBV	O	NOUN	B
,	O	PUNCT	O
were	O	AUX	O
identified	O	VERB	B
,	O	PUNCT	O
but	O	CCONJ	O
we	O	PRON	O
did	O	AUX	O
not	O	PART	O
find	O	VERB	O
any	O	DET	O
evidence	O	NOUN	B
of	O	ADP	O
transcription	O	NOUN	B
from	O	ADP	O
the	O	DET	O
LMP-2A	B-DNA	NOUN	B
or	O	CCONJ	O
EBER-1	B-DNA	NOUN	B
loci	I-DNA	NOUN	I
in	O	ADP	O
infected	O	ADJ	B
thymocytes	B-cell_type	NOUN	B
.	O	PUNCT	O


The	O	DET	O
main	O	ADJ	O
difference	O	NOUN	O
is	O	AUX	O
that	O	SCONJ	O
with	O	ADP	O
thymocytes	B-cell_type	NOUN	B
,	O	PUNCT	O
no	O	DET	O
evidence	O	NOUN	O
could	O	AUX	O
be	O	AUX	O
found	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
virus	O	NOUN	B
ever	O	ADV	O
circularizes	O	VERB	B
.	O	PUNCT	O


Rather	O	ADV	O
,	O	PUNCT	O
EBV	O	NOUN	B
remains	O	VERB	O
in	O	ADP	O
a	O	DET	O
linear	O	ADJ	B
configuration	O	NOUN	I
from	O	ADP	O
which	O	DET	O
replicative	B-DNA	ADJ	B
genes	I-DNA	NOUN	I
are	O	AUX	O
transcribed	O	VERB	B
.	O	PUNCT	O


Identification	O	NOUN	B
and	O	CCONJ	O
purification	O	NOUN	B
of	O	ADP	O
human	B-protein	ADJ	B
Stat	I-protein	NOUN	B
proteins	I-protein	NOUN	I
activated	O	VERB	B
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
interleukin-2	B-protein	NOUN	B
.	O	PUNCT	O


Several	O	ADJ	O
recent	O	ADJ	O
studies	O	NOUN	B
have	O	AUX	O
implicated	O	VERB	O
Jak	O	NOUN	B
kinases	O	NOUN	I
in	O	ADP	O
the	O	DET	O
signaling	O	NOUN	B
pathway	O	NOUN	I
induced	O	VERB	B
by	O	ADP	O
IL-2	B-protein	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
purified	O	VERB	O
these	O	DET	O
activities	O	NOUN	B
and	O	CCONJ	O
found	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
principal	O	ADJ	B
IL-2-inducible	B-protein	ADJ	O
component	I-protein	NOUN	O
bears	O	VERB	O
significant	O	ADJ	O
relatedness	O	NOUN	B
to	O	PART	O
a	O	DET	O
prolactin-induced	B-protein	ADJ	B
transcription	I-protein	NOUN	O
factor	I-protein	NOUN	O
first	O	ADV	O
identified	O	VERB	B
in	O	ADP	O
sheep	B-cell_type	NOUN	B
mammary	I-cell_type	ADJ	B
gland	I-cell_type	NOUN	I
tissue	I-cell_type	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
hypothesize	O	VERB	O
that	O	SCONJ	O
activation	O	NOUN	B
of	O	ADP	O
this	O	DET	O
protein	O	NOUN	B
,	O	PUNCT	O
designated	O	VERB	O
hStat5	B-protein	NOUN	B
,	O	PUNCT	O
helps	O	VERB	O
govern	O	VERB	O
the	O	DET	O
biological	O	ADJ	B
effects	O	NOUN	B
of	O	ADP	O
IL-2	B-protein	NOUN	B
during	O	ADP	O
the	O	DET	O
immune	O	ADJ	B
response	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
demonstrate	O	VERB	O
,	O	PUNCT	O
through	O	ADP	O
the	O	DET	O
deletion	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
UDG	I-DNA	NOUN	O
promoter	I-DNA	NOUN	O
sequences	I-DNA	NOUN	O
,	O	PUNCT	O
that	O	SCONJ	O
expression	O	NOUN	B
of	O	ADP	O
E2F-1	B-protein	NOUN	B
activates	O	VERB	B
the	O	DET	O
UDG	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
through	O	ADP	O
several	O	ADJ	O
E2F	B-DNA	NOUN	B
sites	I-DNA	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
also	O	ADV	O
provide	O	VERB	O
evidence	O	NOUN	B
for	O	ADP	O
the	O	DET	O
functional	O	ADJ	B
relationship	O	NOUN	B
between	O	ADP	O
the	O	DET	O
cyclin-like	B-protein	ADJ	B
UDG	I-protein	NOUN	B
gene	I-protein	NOUN	I
product	I-protein	NOUN	O
and	O	CCONJ	O
E2F	B-protein	NOUN	B
.	O	PUNCT	O


High	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
UDG	B-protein	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
a	O	DET	O
transient	O	ADJ	B
transfection	O	NOUN	O
assay	O	NOUN	O
result	O	VERB	O
in	O	ADP	O
the	O	DET	O
down-regulation	O	NOUN	B
of	O	ADP	O
transcriptional	O	ADJ	B
activity	O	NOUN	I
through	O	ADP	O
elements	B-DNA	NOUN	B
specific	O	ADJ	B
for	O	ADP	O
E2F	B-protein	NOUN	B
-mediated	O	ADJ	O
transcription	O	NOUN	B
.	O	PUNCT	O


Cellular	O	ADJ	B
and	O	CCONJ	O
molecular	O	ADJ	B
mechanisms	O	NOUN	I
of	O	ADP	O
IFN-gamma	B-protein	NOUN	B
production	O	NOUN	B
induced	O	VERB	B
by	O	ADP	O
IL-2	B-protein	NOUN	B
and	O	CCONJ	O
IL-12	B-protein	NOUN	B
in	O	ADP	O
a	O	DET	O
human	B-cell_line	ADJ	B
NK	I-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
particular	O	ADJ	O
,	O	PUNCT	O
two	O	NUM	O
interleukins	B-protein	NOUN	B
(	O	PUNCT	O
ILs	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
IL-2	B-protein	NOUN	B
and	O	CCONJ	O
IL-12	B-protein	NOUN	B
,	O	PUNCT	O
have	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
be	O	AUX	O
potent	O	ADJ	O
inducers	O	NOUN	B
of	O	ADP	O
IFN-gamma	B-protein	NOUN	B
gene	O	NOUN	B
expression	O	NOUN	I
in	O	ADP	O
both	O	CCONJ	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
LGL	B-cell_type	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
report	O	NOUN	O
we	O	PRON	O
present	O	VERB	O
evidence	O	NOUN	B
that	O	SCONJ	O
the	O	DET	O
cell	B-cell_line	NOUN	B
line	I-cell_line	NOUN	I
NK3.3	I-cell_line	NOUN	B
derived	O	VERB	O
from	O	ADP	O
human	B-cell_type	ADJ	B
NK	I-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
responds	O	VERB	O
to	O	PART	O
both	O	CCONJ	O
IL-2	B-protein	NOUN	B
and	O	CCONJ	O
IL-12	B-protein	NOUN	B
,	O	PUNCT	O
as	O	ADP	O
measured	O	VERB	B
by	O	ADP	O
increases	O	NOUN	B
in	O	ADP	O
IFN-gamma	B-protein	NOUN	B
and	O	CCONJ	O
granulocyte-macrophage	B-protein	ADJ	B
colony-stimulating	I-protein	ADJ	I
factor	I-protein	NOUN	I
(	O	PUNCT	O
GM-CSF	B-protein	NOUN	B
)	O	PUNCT	O
cytoplasmic	O	ADJ	B
mRNA	O	NOUN	B
and	O	CCONJ	O
protein	O	NOUN	B
expression	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
when	O	SCONJ	O
used	O	VERB	O
together	O	ADV	O
IL-2	B-protein	NOUN	B
and	O	CCONJ	O
IL-12	B-protein	NOUN	B
synergized	O	VERB	B
in	O	ADP	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
IFN-gamma	B-protein	NOUN	B
and	O	CCONJ	O
GM-CSF	B-protein	NOUN	B
and	O	CCONJ	O
this	O	DET	O
synergy	O	NOUN	B
was	O	AUX	O
attributed	O	VERB	O
to	O	PART	O
an	O	DET	O
increased	O	VERB	B
accumulation	O	NOUN	B
and	O	CCONJ	O
stability	O	NOUN	B
of	O	ADP	O
the	O	DET	O
IFN-gamma	B-RNA	NOUN	B
and	I-RNA	CCONJ	O
GM-CSF	I-RNA	NOUN	B
mRNAs	I-RNA	NOUN	B
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
both	O	CCONJ	O
transforming	B-protein	VERB	B
growth	I-protein	NOUN	I
factor-beta	I-protein	NOUN	I
and	O	CCONJ	O
genistein	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
tyrosine	O	NOUN	B
kinase	O	NOUN	I
inhibitor	O	NOUN	I
,	O	PUNCT	O
could	O	AUX	O
suppress	O	VERB	B
IL-2	B-protein	NOUN	B
and	O	CCONJ	O
IL-12	B-protein	NOUN	B
signaling	O	NOUN	B
but	O	CCONJ	O
CsA	O	NOUN	B
was	O	AUX	O
generally	O	ADV	O
inactive	O	ADJ	B
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
IL-2	B-protein	NOUN	B
and	O	CCONJ	O
IL-12	B-protein	NOUN	B
may	O	AUX	O
have	O	AUX	O
distinct	O	ADJ	O
signaling	O	NOUN	B
pathways	O	NOUN	I
leading	O	VERB	O
to	O	PART	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
IFN-gamma	B-protein	NOUN	B
and	O	CCONJ	O
GM-CSF	B-protein	NOUN	B
gene	O	NOUN	B
expression	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
that	O	SCONJ	O
the	O	DET	O
NK3.3	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
may	O	AUX	O
serve	O	VERB	O
as	O	ADP	O
a	O	DET	O
novel	O	ADJ	O
model	O	NOUN	B
for	O	ADP	O
dissecting	O	VERB	B
the	O	DET	O
biochemical	O	ADJ	B
and	O	CCONJ	O
molecular	O	ADJ	B
events	O	NOUN	I
involved	O	VERB	O
in	O	ADP	O
these	O	DET	O
pathways	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
functional	O	ADJ	B
T-cell	B-protein	NOUN	O
receptor	I-protein	NOUN	O
signaling	O	NOUN	O
pathway	O	NOUN	O
is	O	AUX	O
required	O	VERB	O
for	O	ADP	O
p95vav	B-protein	NOUN	B
activity	O	NOUN	I
.	O	PUNCT	O


It	O	PRON	O
contains	O	VERB	O
a	O	DET	O
number	O	NOUN	O
of	O	ADP	O
structural	B-protein	ADJ	B
motifs	I-protein	NOUN	O
,	O	PUNCT	O
including	O	VERB	O
Src	B-protein	NOUN	B
homology	I-protein	NOUN	B
2	I-protein	NUM	I
,	I-protein	PUNCT	O
Src	I-protein	NOUN	B
homology	I-protein	NOUN	O
3	I-protein	NUM	O
,	I-protein	PUNCT	O
and	I-protein	CCONJ	O
pleckstrin	I-protein	NOUN	B
homology	I-protein	NOUN	I
domains	I-protein	NOUN	I
and	O	CCONJ	O
a	O	DET	O
putative	B-protein	ADJ	B
guanine	I-protein	NOUN	I
nucleotide	I-protein	NOUN	I
exchange	I-protein	NOUN	I
domain	I-protein	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
p95vav	B-protein	NOUN	B
synergizes	O	VERB	B
with	O	ADP	I
TCR	B-protein	NOUN	B
stimulation	O	NOUN	B
in	O	ADP	O
inducing	O	VERB	O
NFAT-	O	NOUN	B
and	O	CCONJ	O
interleukin-2-dependent	O	ADJ	B
transcription	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
further	O	ADV	O
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
p95vav	B-protein	NOUN	B
-induced	O	ADJ	O
NFAT	B-protein	NOUN	B
activation	O	NOUN	B
is	O	AUX	O
not	O	PART	O
mimicked	O	VERB	O
by	O	ADP	O
Ras	B-protein	NOUN	B
activation	O	NOUN	B
,	O	PUNCT	O
though	O	SCONJ	O
its	O	PRON	O
function	O	NOUN	B
is	O	AUX	O
dependent	O	ADJ	O
upon	O	SCONJ	O
Ras	B-protein	NOUN	B
and	O	CCONJ	O
Raf	B-protein	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
overexpression	O	NOUN	B
of	O	ADP	O
p95vav	B-protein	NOUN	B
does	O	AUX	O
not	O	PART	O
appear	O	VERB	O
to	O	PART	O
influence	O	VERB	B
TCR	B-protein	NOUN	B
-induced	O	ADJ	O
protein	O	NOUN	B
tyrosine	O	NOUN	I
phosphorylation	O	NOUN	B
or	O	CCONJ	O
increases	O	VERB	B
in	O	ADP	O
cytoplasmic	O	ADJ	B
free	O	ADJ	I
calcium	O	NOUN	I
.	O	PUNCT	O


Positive	O	ADJ	B
and	O	CCONJ	O
negative	O	ADJ	B
regulation	O	NOUN	O
of	O	ADP	O
granulocyte-macrophage	B-protein	ADJ	B
colony-stimulating	I-protein	ADJ	I
factor	I-protein	NOUN	I
promoter	O	NOUN	B
activity	O	NOUN	I
by	O	ADP	O
AML1-related	B-protein	ADJ	B
transcription	I-protein	NOUN	I
factor	I-protein	NOUN	I
,	O	PUNCT	O
PEBP2	B-protein	NOUN	B
.	O	PUNCT	O


There	O	PRON	O
are	O	AUX	O
at	O	ADP	O
least	O	ADJ	O
two	O	NUM	O
genes	O	NOUN	B
,	O	PUNCT	O
alpha	B-DNA	NOUN	B
A	I-DNA	NOUN	I
and	O	CCONJ	O
alpha	B-DNA	NOUN	B
B	I-DNA	NOUN	I
,	O	PUNCT	O
encoding	O	VERB	B
the	O	DET	O
alpha	B-protein	NOUN	B
subunit	I-protein	NOUN	I
.	O	PUNCT	O


alpha	B-DNA	NOUN	B
B	I-DNA	NOUN	I
is	O	AUX	O
the	O	DET	O
mouse	B-DNA	NOUN	B
homologue	I-DNA	NOUN	B
of	O	ADP	O
human	B-DNA	ADJ	B
AML1	I-DNA	NOUN	O
gene	I-DNA	NOUN	O
detected	O	VERB	B
at	O	ADP	O
the	O	DET	O
breakpoints	O	NOUN	B
of	O	ADP	O
t	O	NOUN	O
(	O	PUNCT	O
8	O	NUM	O
;	O	PUNCT	O
21	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
t	O	NOUN	O
(	O	PUNCT	O
3	O	NUM	O
;	O	PUNCT	O
21	O	NUM	O
)	O	PUNCT	O
myeloid	O	ADJ	B
leukemias	O	NOUN	I
.	O	PUNCT	O


PEBP2	B-protein	NOUN	B
alpha	I-protein	NOUN	I
A1	I-protein	NOUN	I
and	O	CCONJ	O
alpha	B-protein	NOUN	B
B1	I-protein	NOUN	I
enhanced	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
GM-CSF	B-DNA	NOUN	B
promoter-driven	I-DNA	ADJ	B
reporter	I-DNA	NOUN	I
plasmid	I-DNA	NOUN	I
in	O	ADP	O
unstimulated	B-cell_line	ADJ	B
and	I-cell_line	CCONJ	O
12-O-tetradecanoylphorbol	I-cell_line	NOUN	O
13-acetate/phytohemagglutinin-stimulated	I-cell_line	ADJ	O
human	I-cell_line	ADJ	B
Jurkat	I-cell_line	NOUN	O
T	I-cell_line	NOUN	O
cells	I-cell_line	NOUN	O
.	O	PUNCT	O


Coexpression	O	NOUN	B
of	O	ADP	O
alpha	B-protein	NOUN	B
B1	I-protein	NOUN	I
and	O	CCONJ	O
alpha	B-protein	NOUN	B
B2	I-protein	NOUN	I
showed	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
promoter	O	NOUN	B
activity	O	NOUN	I
could	O	AUX	O
be	O	AUX	O
determined	O	VERB	O
by	O	ADP	O
the	O	DET	O
alpha	B-protein	NOUN	B
B1	I-protein	NOUN	I
/alpha	B-protein	NOUN	I
B2	I-protein	NOUN	I
ratio	O	NOUN	B
.	O	PUNCT	O


Although	O	SCONJ	O
further	O	ADJ	O
studies	O	NOUN	B
are	O	AUX	O
required	O	VERB	O
to	O	PART	O
determine	O	VERB	O
the	O	DET	O
precise	O	ADJ	O
role	O	NOUN	O
of	O	ADP	O
PEBP2	B-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
GM-CSF	B-protein	NOUN	B
promoter	O	NOUN	B
activity	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
present	O	ADJ	O
findings	O	NOUN	B
suggested	O	VERB	O
the	O	DET	O
importance	O	NOUN	O
of	O	ADP	O
the	O	DET	O
relative	O	ADJ	O
ratio	O	NOUN	B
of	O	ADP	O
different	O	ADJ	O
PEBP2	B-protein	NOUN	B
isoforms	I-protein	NOUN	B
in	O	ADP	O
regulating	O	VERB	B
the	O	DET	O
levels	O	NOUN	B
of	O	ADP	O
the	O	DET	O
promoter	O	NOUN	B
activity	O	NOUN	I
.	O	PUNCT	O


IFN-gamma	B-protein	NOUN	B
priming	O	NOUN	B
of	O	ADP	O
monocytes	B-cell_type	NOUN	B
enhances	O	VERB	O
LPS-induced	O	ADJ	B
TNF	B-protein	NOUN	B
production	O	NOUN	B
by	O	ADP	O
augmenting	O	VERB	O
both	O	CCONJ	O
transcription	O	NOUN	B
and	O	CCONJ	O
MRNA	O	NOUN	B
stability	O	NOUN	I
.	O	PUNCT	O


Using	O	VERB	O
tumour	B-protein	NOUN	B
necrosis	I-protein	NOUN	I
factor	I-protein	NOUN	I
(	O	PUNCT	O
TNF	B-protein	NOUN	B
)	O	PUNCT	O
induction	O	NOUN	B
as	O	ADP	O
a	O	DET	O
model	O	NOUN	B
,	O	PUNCT	O
experiments	O	NOUN	B
were	O	AUX	O
designed	O	VERB	O
to	O	PART	O
analyse	O	VERB	B
in	O	ADP	O
detail	O	NOUN	O
the	O	DET	O
priming	O	NOUN	B
effect	O	NOUN	B
on	O	ADP	O
the	O	DET	O
LPS	O	NOUN	B
response	O	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
monocytes	I-cell_type	NOUN	B
.	O	PUNCT	O


IFN-gamma	B-protein	NOUN	B
pre-treatment	O	NOUN	B
affected	O	VERB	B
the	O	DET	O
magnitude	O	NOUN	B
rather	O	ADV	O
than	O	ADP	O
the	O	DET	O
sensitivity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
LPS	O	NOUN	B
response	O	NOUN	B
.	O	PUNCT	O


Primed	O	ADJ	B
monocytes	B-cell_type	NOUN	O
transcribed	O	VERB	O
TNF	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
at	O	ADP	O
a	O	DET	O
higher	O	ADJ	O
rate	O	NOUN	B
than	O	ADP	O
freshly	O	ADV	O
isolated	O	VERB	B
monocytes	B-cell_type	NOUN	B
upon	O	SCONJ	O
activation	O	NOUN	B
with	O	ADP	O
LPS	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
increased	O	VERB	B
transcriptional	O	ADJ	B
rate	O	NOUN	I
correlated	O	VERB	B
with	O	ADP	O
a	O	DET	O
marked	O	ADJ	O
increase	O	NOUN	B
in	O	ADP	O
nuclear	B-protein	ADJ	B
factor-kappa	I-protein	NOUN	I
B	I-protein	NOUN	I
activity	O	NOUN	I
in	O	ADP	O
these	O	DET	O
cells	O	NOUN	B
as	O	ADP	O
determined	O	VERB	O
by	O	ADP	O
electrophoretic	O	ADJ	B
mobility	O	NOUN	I
shift	O	NOUN	I
assay	O	NOUN	I
using	O	VERB	O
a	O	DET	O
consensus	B-DNA	NOUN	B
NF-kappa	I-DNA	NOUN	I
B	I-DNA	NOUN	I
oligonucleotide	I-DNA	NOUN	I
.	O	PUNCT	O


Using	O	VERB	O
biochemical	O	ADJ	B
and	O	CCONJ	O
mutagenesis	O	NOUN	B
analyses	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
determined	O	VERB	O
that	O	SCONJ	O
multiple	O	ADJ	B
nuclear	B-protein	ADJ	B
factors	I-protein	NOUN	I
bind	O	VERB	B
to	O	PART	O
these	O	DET	O
independent	O	ADJ	O
sites	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
determined	O	VERB	O
that	O	SCONJ	O
an	O	DET	O
initiator-like	B-DNA	ADJ	B
sequence	I-DNA	NOUN	I
present	O	ADJ	O
at	O	ADP	O
the	O	DET	O
cap	B-DNA	NOUN	B
site	I-DNA	NOUN	I
and	O	CCONJ	O
an	O	DET	O
Ets	B-DNA	NOUN	B
consensus	I-DNA	NOUN	I
sequence	I-DNA	NOUN	I
are	O	AUX	O
required	O	VERB	O
for	O	ADP	O
full	O	ADJ	O
promoter	B-DNA	NOUN	B
function	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
therefore	O	ADV	O
believe	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
MAZ	B-protein	NOUN	B
transcription	I-protein	NOUN	B
factor	I-protein	NOUN	I
is	O	AUX	O
also	O	ADV	O
likely	O	ADJ	O
to	O	PART	O
play	O	VERB	O
an	O	DET	O
important	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
control	O	NOUN	B
of	O	ADP	O
developmental	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
the	O	DET	O
CD4	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
.	O	PUNCT	O


The	O	DET	O
protein	B-protein	NOUN	B
products	I-protein	NOUN	I
of	O	ADP	O
this	O	DET	O
gene	O	NOUN	B
contain	O	VERB	O
the	O	DET	O
basic-helix-loop-helix	B-protein	ADJ	B
motif	I-protein	NOUN	I
characteristic	O	ADJ	I
of	O	ADP	O
a	O	DET	O
large	O	ADJ	O
family	O	NOUN	O
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
that	O	PRON	O
bind	O	VERB	B
to	O	PART	O
the	O	DET	O
canonical	B-DNA	ADJ	B
DNA	I-DNA	NOUN	I
sequence	I-DNA	NOUN	I
CANNTG	I-DNA	NOUN	I
as	O	ADP	O
protein	B-protein	NOUN	B
heterodimers	I-protein	NOUN	I
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
Epo	B-protein	NOUN	B
acts	O	VERB	O
at	O	ADP	O
both	O	CCONJ	O
transcriptional	O	ADJ	B
and	O	CCONJ	O
posttranscriptional	O	ADJ	B
levels	O	NOUN	O
on	O	ADP	O
the	O	DET	O
TAL1	B-protein	NOUN	B
locus	O	NOUN	B
in	O	ADP	O
Friend	B-cell_line	NOUN	B
virus-induced	I-cell_line	ADJ	I
erythroblasts	I-cell_line	NOUN	I
and	O	CCONJ	O
establish	O	VERB	O
a	O	DET	O
link	O	NOUN	O
between	O	ADP	O
Epo	B-protein	NOUN	B
signaling	O	NOUN	O
mechanisms	O	NOUN	B
and	O	CCONJ	O
a	O	DET	O
member	O	NOUN	B
of	O	ADP	O
a	O	DET	O
family	O	NOUN	B
of	O	ADP	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
differentiation	O	NOUN	B
of	O	ADP	O
diverse	B-cell_type	ADJ	B
cell	I-cell_type	NOUN	B
lineages	I-cell_type	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
describe	O	VERB	O
a	O	DET	O
method	O	NOUN	B
for	O	ADP	O
relative	O	ADJ	O
quantification	O	NOUN	B
of	O	ADP	O
specific	O	ADJ	O
mRNA	B-RNA	NOUN	B
using	O	VERB	O
a	O	DET	O
nonradioactive	O	ADJ	B
assay	O	NOUN	I
based	O	VERB	O
on	O	ADP	O
DNA	O	NOUN	B
strand	O	NOUN	I
competition	O	NOUN	B
between	O	ADP	O
identical	O	ADJ	B
sequences	O	NOUN	B
of	O	ADP	O
biotin-	O	NOUN	B
and	O	CCONJ	O
fluorescein-labeled	O	ADJ	B
amplicon	O	NOUN	I
(	O	PUNCT	O
probe	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
unlabeled	O	ADJ	B
amplicon	O	NOUN	I
(	O	PUNCT	O
target	O	NOUN	B
)	O	PUNCT	O
during	O	ADP	O
hybridization	O	NOUN	B
.	O	PUNCT	O


This	O	DET	O
technique	O	NOUN	B
was	O	AUX	O
successfully	O	ADV	O
applied	O	VERB	O
to	O	PART	O
evaluate	O	VERB	B
differences	O	NOUN	B
in	O	ADP	O
glucocorticoid	B-protein	NOUN	B
receptor	I-protein	NOUN	I
expression	O	NOUN	B
in	O	ADP	O
U937	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
before	O	ADP	O
and	O	CCONJ	O
after	O	ADP	O
the	O	DET	O
addition	O	NOUN	O
of	O	ADP	O
potent	O	ADJ	O
differentiation	O	NOUN	B
inducers	O	NOUN	B
:	O	PUNCT	O
12-O-tetradecanoylphorbol	O	NOUN	O
13-acetate	O	NOUN	O
(	O	PUNCT	O
TPA	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
combination	O	NOUN	B
of	O	ADP	O
all-trans	O	ADJ	B
retinoic	O	ADJ	I
acid	O	NOUN	I
(	O	PUNCT	O
RA	O	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
1	O	NUM	O
,	O	PUNCT	O
25-dihydroxyvitamin	O	NOUN	B
D2	O	NOUN	I
(	O	PUNCT	O
VD	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
to	O	PART	O
the	O	DET	O
purely	O	ADV	O
enhancer-dependent	O	ADJ	B
effect	O	NOUN	O
of	O	ADP	O
cytokines	B-protein	NOUN	B
such	O	ADJ	O
as	O	ADP	O
TNF	B-protein	NOUN	B
on	O	ADP	O
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
HIV	B-DNA	NOUN	B
regulatory	I-DNA	ADJ	O
region	I-DNA	NOUN	O
(	O	PUNCT	O
LTR	B-DNA	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
we	O	PRON	O
observed	O	VERB	O
that	O	SCONJ	O
okadaic	O	ADJ	B
acid	O	NOUN	I
(	O	PUNCT	O
OKA	O	NOUN	B
)	O	PUNCT	O
activates	O	VERB	B
HIV	O	NOUN	B
transcription	O	NOUN	O
through	O	ADP	O
both	O	CCONJ	O
the	O	DET	O
enhancer	O	NOUN	B
,	O	PUNCT	O
responding	O	VERB	B
to	O	PART	O
the	O	DET	O
factor	O	NOUN	B
NF-kappa	B-protein	NOUN	I
B	I-protein	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
promoter	B-DNA	NOUN	B
domain	I-DNA	NOUN	I
of	O	ADP	O
the	O	DET	O
LTR	B-DNA	NOUN	B
.	O	PUNCT	O


Responsiveness	O	NOUN	B
of	O	ADP	O
LTR	B-DNA	NOUN	B
constructs	I-DNA	NOUN	B
deleted	O	VERB	O
of	O	ADP	O
kappa	B-DNA	NOUN	B
B	I-DNA	NOUN	I
elements	I-DNA	NOUN	I
to	O	PART	O
HIV	B-protein	NOUN	B
Tat	I-protein	NOUN	B
expression	O	NOUN	B
was	O	AUX	O
increased	O	VERB	B
upon	O	SCONJ	O
OKA	O	NOUN	B
but	O	CCONJ	O
not	O	PART	O
TNF	B-protein	NOUN	B
stimulation	O	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	O
suggest	O	VERB	O
that	O	SCONJ	O
SP1	B-protein	NOUN	B
phosphorylation	O	NOUN	B
induced	O	VERB	B
by	O	ADP	O
OKA	O	NOUN	B
,	O	PUNCT	O
a	O	DET	O
selective	O	ADJ	O
inhibitor	O	NOUN	B
of	O	ADP	O
the	O	DET	O
serine-threonine	B-protein	ADJ	B
phosphatase	I-protein	NOUN	I
PP2A	B-protein	NOUN	B
,	O	PUNCT	O
facilitates	O	VERB	O
the	O	DET	O
formation	O	NOUN	B
of	O	ADP	O
a	O	DET	O
transcription	B-protein	NOUN	B
complex	I-protein	NOUN	I
involving	O	VERB	O
general	O	ADJ	O
transcription	B-protein	NOUN	B
factors	I-protein	NOUN	I
,	O	PUNCT	O
HIV	B-protein	NOUN	B
Tat	I-protein	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
Sp1	B-protein	NOUN	B
proteins	I-protein	NOUN	I
.	O	PUNCT	O


To	O	PART	O
understand	O	VERB	O
the	O	DET	O
molecular	O	ADJ	B
bases	O	NOUN	I
for	O	ADP	O
cytokine	O	NOUN	B
redundancy	O	NOUN	B
and	O	CCONJ	O
pleiotropy	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
have	O	AUX	O
compared	O	VERB	B
the	O	DET	O
Stat	B-protein	NOUN	B
proteins	I-protein	NOUN	I
activated	O	VERB	B
in	O	ADP	O
peripheral	B-cell_type	ADJ	B
blood	I-cell_type	NOUN	I
lymphocytes	I-cell_type	NOUN	I
(	O	PUNCT	O
PBLs	B-cell_type	NOUN	B
)	O	PUNCT	O
by	O	ADP	O
cytokines	B-protein	NOUN	B
with	O	ADP	O
shared	O	VERB	B
and	O	CCONJ	O
distinct	O	ADJ	O
actions	O	NOUN	B
.	O	PUNCT	O


IL-7	B-protein	NOUN	B
and	O	CCONJ	O
IL-15	B-protein	NOUN	B
induced	O	VERB	B
the	O	DET	O
same	O	ADJ	O
complexes	O	NOUN	B
as	O	ADP	O
IL-2	B-protein	NOUN	B
,	O	PUNCT	O
a	O	DET	O
feature	O	NOUN	O
explained	O	VERB	O
by	O	ADP	O
the	O	DET	O
existence	O	NOUN	O
of	O	ADP	O
similar	O	ADJ	O
tyrosine-phosphorylated	B-protein	ADJ	B
motifs	I-protein	NOUN	B
in	O	ADP	O
the	O	DET	O
cytoplasmic	B-protein	ADJ	B
domains	I-protein	NOUN	I
of	O	ADP	O
IL-2R	B-protein	NOUN	B
beta	I-protein	NOUN	B
and	O	CCONJ	O
IL-7R	B-protein	NOUN	B
that	O	PRON	O
can	O	AUX	O
serve	O	VERB	O
as	O	ADP	O
docking	O	NOUN	B
sites	O	NOUN	I
for	O	ADP	O
Stat	B-protein	NOUN	B
proteins	I-protein	NOUN	I
.	O	PUNCT	O


These	O	DET	O
studies	O	NOUN	B
demonstrate	O	VERB	O
that	O	SCONJ	O
a	O	DET	O
single	O	ADJ	O
cytokine	B-protein	NOUN	B
can	O	AUX	O
activate	O	VERB	B
different	O	ADJ	O
combinations	O	NOUN	B
of	O	ADP	O
Stat	B-protein	NOUN	B
proteins	I-protein	NOUN	I
under	O	ADP	O
different	O	ADJ	O
physiological	O	ADJ	B
conditions	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
also	O	ADV	O
indicate	O	VERB	O
two	O	NUM	O
mechanisms	O	NOUN	B
by	O	ADP	O
which	O	DET	O
distinct	O	ADJ	O
cytokines	B-protein	NOUN	B
can	O	AUX	O
activate	O	VERB	B
the	O	DET	O
same	O	ADJ	O
Stat	B-protein	NOUN	B
protein	I-protein	NOUN	I
.	O	PUNCT	O


Various	O	ADJ	O
stimuli	O	NOUN	B
,	O	PUNCT	O
typically	O	ADV	O
those	O	DET	O
associated	O	VERB	B
with	O	ADP	I
stress	O	NOUN	B
or	O	CCONJ	O
pathogens	O	NOUN	B
,	O	PUNCT	O
rapidly	O	ADV	O
inactivate	O	VERB	O
I	B-protein	NOUN	O
kappa	I-protein	NOUN	O
B-alpha	I-protein	NOUN	B
.	O	PUNCT	O


When	O	SCONJ	O
either	O	CCONJ	O
serine-32	O	NOUN	B
or	O	CCONJ	O
serine-36	O	NOUN	B
of	O	ADP	O
I	B-protein	NOUN	O
kappa	I-protein	NOUN	O
B-alpha	I-protein	NOUN	O
was	O	AUX	O
mutated	O	VERB	B
,	O	PUNCT	O
the	O	DET	O
protein	O	NOUN	B
did	O	AUX	O
not	O	PART	O
undergo	O	VERB	O
signal-induced	O	ADJ	B
phosphorylation	O	NOUN	B
or	O	CCONJ	O
degradation	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
NF-kappa	B-protein	NOUN	B
B	I-protein	NOUN	I
could	O	AUX	O
not	O	PART	O
be	O	AUX	O
activated	O	VERB	B
.	O	PUNCT	O


Regulation	O	NOUN	B
of	O	ADP	O
transcription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-DNA	ADJ	B
erythropoietin	I-DNA	NOUN	I
receptor	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
by	O	ADP	O
proteins	O	NOUN	B
binding	O	VERB	I
to	O	PART	O
GATA-1	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
Sp1	I-DNA	NOUN	B
motifs	I-DNA	NOUN	B
.	O	PUNCT	O


Erythropoietin	B-protein	NOUN	B
(	O	PUNCT	O
Epo	B-protein	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
the	O	DET	O
primary	O	ADJ	B
regulator	O	NOUN	I
of	O	ADP	O
the	O	DET	O
production	O	NOUN	B
of	O	ADP	O
erythroid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
acts	O	VERB	O
by	O	ADP	O
binding	O	VERB	B
to	O	PART	O
a	O	DET	O
cell	B-protein	NOUN	B
surface	I-protein	NOUN	I
receptor	I-protein	NOUN	I
(	O	PUNCT	O
EpoR	B-protein	NOUN	B
)	O	PUNCT	O
on	O	ADP	O
erythroid	B-cell_type	ADJ	B
progenitors	I-cell_type	NOUN	B
.	O	PUNCT	O


The	O	DET	O
150	B-DNA	NUM	O
bp	I-DNA	NOUN	O
hEpoR	I-DNA	NOUN	B
promoter	I-DNA	NOUN	B
exhibited	O	VERB	O
high	O	ADJ	B
and	O	CCONJ	O
low	O	ADJ	O
activity	O	NOUN	B
in	O	ADP	O
erythroid	O	ADJ	B
OCIM1	B-cell_line	NOUN	I
and	O	CCONJ	O
K562	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
,	O	PUNCT	O
respectively	O	ADV	O
,	O	PUNCT	O
reflecting	O	VERB	O
the	O	DET	O
high	O	ADJ	B
and	O	CCONJ	O
low	O	ADJ	B
levels	O	NOUN	B
of	O	ADP	O
constitutive	O	ADJ	B
hEpoR	B-protein	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
GATA-1	B-DNA	NOUN	B
and	I-DNA	CCONJ	O
Sp1	I-DNA	NOUN	B
binding	I-DNA	NOUN	B
sites	I-DNA	NOUN	I
in	O	ADP	O
this	O	DET	O
promoter	O	NOUN	B
lacking	O	VERB	O
a	O	DET	O
TATA	B-DNA	NOUN	B
sequence	I-DNA	NOUN	O
were	O	AUX	O
necessary	O	ADJ	O
for	O	ADP	O
a	O	DET	O
high	O	ADJ	O
level	O	NOUN	B
of	O	ADP	O
transcription	O	NOUN	B
activation	O	NOUN	I
.	O	PUNCT	O


By	O	ADP	O
increasing	O	VERB	O
GATA-1	B-protein	NOUN	B
levels	O	NOUN	B
via	O	ADP	O
co-transfection	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
were	O	AUX	O
able	O	ADJ	O
to	O	PART	O
transactivate	O	VERB	B
the	O	DET	O
hEpoR	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
in	O	ADP	O
K562	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
and	O	CCONJ	O
non-erythroid	B-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
in	O	ADP	O
the	O	DET	O
highly	O	ADV	O
active	O	ADJ	O
OCIM1	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
,	O	PUNCT	O
although	O	SCONJ	O
GATA-1	B-RNA	NOUN	B
mRNA	I-RNA	NOUN	B
levels	O	NOUN	O
were	O	AUX	O
comparable	O	ADJ	O
in	O	ADP	O
OCIM1	B-cell_line	NOUN	B
and	O	CCONJ	O
K562	B-cell_line	NOUN	B
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
while	O	SCONJ	O
GATA-1	B-protein	NOUN	B
can	O	AUX	O
transactivate	O	VERB	B
the	O	DET	O
EpoR	B-DNA	NOUN	B
promoter	I-DNA	NOUN	B
,	O	PUNCT	O
the	O	DET	O
level	O	NOUN	B
of	O	ADP	O
hEpoR	B-DNA	NOUN	B
gene	I-DNA	NOUN	B
expression	O	NOUN	I
does	O	AUX	O
not	O	PART	O
depend	O	VERB	O
on	O	ADP	O
GATA-1	B-protein	NOUN	B
alone	O	ADV	O
.	O	PUNCT	O


The	O	DET	O
deduced	O	VERB	O
amino	O	NOUN	B
acid	O	NOUN	I
sequence	O	NOUN	I
similarity	O	NOUN	B
to	O	PART	O
the	O	DET	O
proteins	O	NOUN	B
encoded	O	VERB	B
by	O	ADP	O
these	O	DET	O
two	O	NUM	O
latter	O	ADJ	O
genes	O	NOUN	B
is	O	AUX	O
approximately	O	ADV	O
65	O	NUM	O
%	O	NOUN	O
and	O	CCONJ	O
includes	O	VERB	O
domains	O	NOUN	B
and	O	CCONJ	O
amino	O	NOUN	B
acid	O	NOUN	I
residues	O	NOUN	I
(	O	PUNCT	O
the	O	DET	O
leucine	B-protein	NOUN	B
zipper-like	I-protein	ADJ	B
and	O	CCONJ	O
the	O	DET	O
RGD	B-protein	NOUN	B
domain	I-protein	NOUN	O
,	O	PUNCT	O
a	O	DET	O
serine	O	NOUN	B
and	O	CCONJ	O
a	O	DET	O
histidine	O	NOUN	B
residue	O	NOUN	B
in	O	ADP	O
the	O	DET	O
NH2-	B-protein	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
the	O	DET	O
COOH-terminal	B-protein	ADJ	B
portion	I-protein	NOUN	I
of	O	ADP	O
the	O	DET	O
protein	O	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
)	O	PUNCT	O
postulated	O	VERB	O
to	O	PART	O
be	O	AUX	O
important	O	ADJ	O
for	O	ADP	O
nm23	B-protein	NOUN	B
function	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
observed	O	VERB	O
that	O	SCONJ	O
Fc	B-protein	NOUN	B
gamma	I-protein	NOUN	I
RI	I-protein	NOUN	I
transcript	O	NOUN	B
levels	O	NOUN	B
in	O	ADP	O
monoblast-like	B-cell_line	ADJ	B
U937	I-cell_line	NOUN	I
cells	I-cell_line	NOUN	I
were	O	AUX	O
elevated	O	ADJ	B
within	O	ADP	O
3	O	NUM	O
hr	O	NOUN	O
and	O	CCONJ	O
peaked	O	VERB	O
12	O	NUM	O
hr	O	NOUN	O
after	O	ADP	O
exposure	O	NOUN	B
to	O	PART	I
IFN-gamma	B-protein	NOUN	B
.	O	PUNCT	O


Constitutively	O	ADV	B
activated	O	VERB	B
Jak	B-protein	NOUN	B
-STAT	B-protein	ADJ	I
pathway	O	NOUN	I
in	O	ADP	O
T	B-cell_type	NOUN	B
cells	I-cell_type	NOUN	I
transformed	O	VERB	O
with	O	ADP	O
HTLV-I	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
HTLV-I-infected	B-cell_line	ADJ	B
cord	I-cell_line	NOUN	I
blood	I-cell_line	NOUN	O
lymphocytes	I-cell_line	NOUN	O
,	O	PUNCT	O
the	O	DET	O
transition	O	NOUN	B
from	O	ADP	O
IL-2	B-protein	NOUN	B
-dependent	O	ADJ	O
to	O	PART	O
IL-2	B-protein	NOUN	B
-independent	O	ADJ	O
growth	O	NOUN	B
correlated	O	VERB	B
with	O	ADP	O
the	O	DET	O
acquisition	O	NOUN	B
of	O	ADP	O
a	O	DET	O
constitutively	O	ADV	B
activated	O	VERB	B
Jak	B-protein	NOUN	B
-STAT	B-protein	ADJ	I
pathway	O	NOUN	I
,	O	PUNCT	O
which	O	DET	O
suggests	O	VERB	O
that	O	SCONJ	O
this	O	DET	O
pathway	O	NOUN	B
participates	O	VERB	O
in	O	ADP	O
HTLV-I-mediated	O	ADJ	B
T	O	NOUN	I
cell	O	NOUN	I
transformation	O	NOUN	O
.	O	PUNCT	O


Nitric	O	ADJ	B
oxide	O	NOUN	I
decreases	O	VERB	B
cytokine	B-protein	NOUN	B
-induced	O	ADJ	O
endothelial	O	ADJ	B
activation	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
a	O	DET	O
concentration-dependent	O	ADJ	B
manner	O	NOUN	O
,	O	PUNCT	O
NO	O	NOUN	B
inhibited	O	VERB	B
interleukin	B-protein	NOUN	B
(	I-protein	PUNCT	I
IL	I-protein	NOUN	B
)	I-protein	PUNCT	O
-1	I-protein	NUM	O
alpha-stimulated	O	ADJ	O
VCAM-1	B-protein	NOUN	B
expression	O	NOUN	B
by	O	ADP	O
35-55	O	NUM	O
%	O	NOUN	O
as	O	ADP	O
determined	O	VERB	O
by	O	ADP	O
cell	O	NOUN	B
surface	O	NOUN	I
enzyme	O	NOUN	B
immunoassays	O	NOUN	I
and	O	CCONJ	O
flow	O	NOUN	B
cytometry	O	NOUN	I
.	O	PUNCT	O


NO	O	NOUN	B
also	O	ADV	O
decreased	O	VERB	B
the	O	DET	O
endothelial	O	ADJ	B
expression	O	NOUN	B
of	O	ADP	O
other	O	ADJ	O
leukocyte	B-protein	NOUN	B
adhesion	I-protein	NOUN	I
molecules	I-protein	NOUN	I
(	O	PUNCT	O
E-selectin	B-protein	NOUN	B
and	O	CCONJ	O
to	O	PART	O
a	O	DET	O
lesser	O	ADJ	B
extent	O	NOUN	B
,	O	PUNCT	O
intercellular	B-protein	ADJ	B
adhesion	I-protein	NOUN	I
molecule-1	I-protein	NOUN	I
)	O	PUNCT	O
and	O	CCONJ	O
secretable	O	ADJ	B
cytokines	B-protein	NOUN	I
(	O	PUNCT	O
IL-6	B-protein	NOUN	B
and	O	CCONJ	O
IL-8	B-protein	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Secreted	O	VERB	B
from	O	ADP	O
activated	B-cell_type	VERB	B
T	I-cell_type	NOUN	O
cells	I-cell_type	NOUN	O
and	O	CCONJ	O
macrophages	B-cell_type	NOUN	B
,	O	PUNCT	O
bone	O	NOUN	B
marrow-derived	B-protein	ADJ	I
MIP-1	I-protein	NOUN	O
alpha/GOS19	I-protein	DET	O
inhibits	O	VERB	B
primitive	B-cell_type	ADJ	O
hematopoietic	I-cell_type	ADJ	B
stem	I-cell_type	NOUN	I
cells	I-cell_type	NOUN	I
and	O	CCONJ	O
appears	O	VERB	O
to	O	PART	O
be	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
homeostatic	O	ADJ	B
control	O	NOUN	I
of	O	ADP	I
stem	B-cell_type	NOUN	B
cell	I-cell_type	NOUN	I
proliferation	O	NOUN	I
.	O	PUNCT	O


Therefore	O	ADV	O
,	O	PUNCT	O
it	O	PRON	O
is	O	AUX	O
important	O	ADJ	O
to	O	PART	O
understand	O	VERB	O
the	O	DET	O
mechanisms	O	NOUN	B
which	O	DET	O
control	O	VERB	B
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
MIP-1	B-protein	NOUN	B
alpha	I-protein	NOUN	B
/GOS19	B-protein	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
communication	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
provide	O	VERB	O
evidence	O	NOUN	B
that	O	SCONJ	O
the	O	DET	O
pathway	O	NOUN	B
of	O	ADP	O
induction	O	NOUN	B
in	O	ADP	O
the	O	DET	O
macrophage	B-cell_line	NOUN	B
cell	I-cell_line	NOUN	I
line	I-cell_line	NOUN	I
U937	B-cell_line	NOUN	O
is	O	AUX	O
different	O	ADJ	O
from	O	ADP	O
that	O	DET	O
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


A	O	DET	O
mutation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
MNP	B-DNA	NOUN	B
site	I-DNA	NOUN	B
which	O	DET	O
does	O	AUX	O
not	O	PART	O
abrogate	O	VERB	O
ICK-1	O	NOUN	B
binding	O	NOUN	B
inactivates	O	VERB	B
the	O	DET	O
GOS19.1	B-DNA	NOUN	B
promoter	I-DNA	NOUN	I
in	O	ADP	O
U937	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
and	O	CCONJ	O
reduces	O	VERB	B
its	O	PRON	O
activity	O	NOUN	B
by	O	ADP	O
fourfold	O	ADV	O
in	O	ADP	O
Jurkat	B-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
.	O	PUNCT	O


The	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
Toremifene	O	NOUN	B
on	O	ADP	O
the	O	DET	O
expression	O	NOUN	B
of	O	ADP	O
some	O	DET	O
genes	O	NOUN	B
in	O	ADP	O
human	B-cell_type	ADJ	B
mononuclear	I-cell_type	ADJ	B
cells	I-cell_type	NOUN	I
.	O	PUNCT	O


IL-5	B-protein	NOUN	B
also	O	ADV	O
stimulates	O	VERB	B
GTP	O	NOUN	B
binding	O	NOUN	I
to	O	PART	O
p21ras	B-protein	NOUN	B
.	O	PUNCT	O


Jak2	B-protein	NOUN	B
kinase	I-protein	NOUN	I
has	O	AUX	O
been	O	AUX	O
shown	O	VERB	O
to	O	PART	O
phosphorylate	O	VERB	B
STAT	B-protein	NOUN	B
nuclear	I-protein	ADJ	I
proteins	I-protein	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
found	O	VERB	O
that	O	SCONJ	O
IL-5	B-protein	NOUN	B
induces	O	VERB	B
two	O	NUM	O
GAS-binding	B-protein	ADJ	B
proteins	I-protein	NOUN	I
in	O	ADP	O
eosinophils	B-cell_type	NOUN	B
,	O	PUNCT	O
one	O	NUM	O
of	O	ADP	O
which	O	DET	O
is	O	AUX	O
STAT1	B-protein	NOUN	B
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
unlike	O	ADP	O
another	O	DET	O
tumor	B-protein	NOUN	B
suppressor	I-protein	NOUN	I
protein	I-protein	NOUN	I
,	O	PUNCT	O
p53	B-protein	NOUN	B
,	O	PUNCT	O
Rb	B-protein	NOUN	B
did	O	AUX	O
not	O	PART	O
have	O	AUX	O
any	O	DET	O
significant	O	ADJ	O
effect	O	NOUN	B
on	O	ADP	O
basal	O	ADJ	B
levels	O	NOUN	I
of	O	ADP	O
transcription	O	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
Rb	B-protein	NOUN	B
specifically	O	ADV	O
interacts	O	VERB	O
with	O	ADP	O
IE2	B-protein	NOUN	B
rather	O	ADV	O
than	O	ADP	O
other	O	ADJ	O
cellular	B-protein	ADJ	B
factors	I-protein	NOUN	I
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
general	O	ADJ	B
transcription	O	NOUN	I
machinery	O	NOUN	I
.	O	PUNCT	O


Our	O	PRON	O
results	O	NOUN	O
contradict	O	VERB	O
the	O	DET	O
hypothesis	O	NOUN	B
concerning	O	VERB	O
the	O	DET	O
possible	O	ADJ	O
role	O	NOUN	O
of	O	ADP	O
nm23	B-DNA	NOUN	B
gene	I-DNA	NOUN	I
as	O	ADP	O
a	O	DET	O
metastatic	O	ADJ	B
suppressor	O	NOUN	I
gene	O	NOUN	I
in	O	ADP	O
human	O	ADJ	B
skin	O	NOUN	O
cancer	O	NOUN	O
.	O	PUNCT	O


Here	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
Duffy	B-DNA	NOUN	B
antigen/chemokine	I-DNA	NOUN	I
receptor	I-DNA	NOUN	I
gene	I-DNA	NOUN	I
(	O	PUNCT	O
DARC	B-DNA	NOUN	B
)	O	PUNCT	O
is	O	AUX	O
composed	O	VERB	O
of	O	ADP	O
a	O	DET	O
single	O	ADJ	O
exon	B-DNA	NOUN	B
and	O	CCONJ	O
that	O	SCONJ	O
most	O	ADJ	O
Duffy-negative	O	ADJ	B
blacks	O	NOUN	I
carry	O	VERB	O
a	O	DET	O
silent	B-DNA	ADJ	B
FY*B	I-DNA	NOUN	B
allele	I-DNA	NOUN	O
with	O	ADP	O
a	O	DET	O
single	O	ADJ	O
T	O	NOUN	O
to	O	PART	O
C	O	NOUN	O
substitution	O	NOUN	B
at	O	ADP	O
nucleotide	O	NOUN	B
-46	O	NUM	O
.	O	PUNCT	O


It	O	PRON	O
contains	O	VERB	O
a	O	DET	O
core	B-DNA	NOUN	B
sequence	I-DNA	NOUN	I
CTTGG	O	NOUN	B
...	O	PUNCT	O
CCAAG	O	NOUN	B
which	O	DET	O
is	O	AUX	O
present	O	ADJ	O
as	O	ADP	O
part	O	NOUN	O
of	O	ADP	O
larger	O	ADJ	B
palindromic	B-DNA	ADJ	B
sequences	I-DNA	NOUN	I
in	O	ADP	O
each	O	DET	O
gene	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
human	B-cell_line	ADJ	B
T	I-cell_line	NOUN	O
lymphoid	I-cell_line	ADJ	O
cell	I-cell_line	NOUN	O
line	I-cell_line	NOUN	O
,	O	PUNCT	O
PEER	B-cell_line	NOUN	B
,	O	PUNCT	O
dies	O	VERB	B
by	O	ADP	O
apoptosis	O	NOUN	B
in	O	ADP	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
PMA	O	NOUN	B
and	O	CCONJ	O
calcium	O	NOUN	B
ionophore	O	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
real	O	ADJ	O
effect	O	NOUN	O
of	O	ADP	O
hormones	O	NOUN	B
involved	O	VERB	O
in	O	ADP	O
ovulation	O	NOUN	B
is	O	AUX	O
expressed	O	VERB	B
by	O	ADP	O
biological	O	ADJ	B
modifications	O	NOUN	B
on	O	ADP	O
target	B-cell_type	NOUN	B
tissues	I-cell_type	NOUN	B
.	O	PUNCT	O


The	O	DET	O
responses	O	NOUN	B
of	O	ADP	O
PBMC	B-cell_type	NOUN	B
from	O	ADP	O
Graves	O	NOUN	B
'	O	PART	I
patients	O	NOUN	B
before	O	ADP	O
RAI	O	NOUN	B
therapy	O	NOUN	B
were	O	AUX	O
less	O	ADJ	O
than	O	ADP	O
those	O	DET	O
in	O	ADP	O
the	O	DET	O
presurgical	O	ADJ	B
group	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
difference	O	NOUN	O
in	O	ADP	O
the	O	DET	O
number	O	NOUN	O
of	O	ADP	O
recognized	O	VERB	O
peptides	O	NOUN	B
by	O	ADP	O
patients	O	NOUN	B
'	O	PART	O
PBMC	B-cell_type	NOUN	B
before	O	ADP	O
RAI	O	NOUN	B
and	O	CCONJ	O
surgery	O	NOUN	B
may	O	AUX	O
reflect	O	VERB	O
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
long	O	ADJ	B
term	O	NOUN	I
therapy	O	NOUN	I
with	O	ADP	O
ATD	O	NOUN	B
in	O	ADP	O
the	O	DET	O
patients	O	NOUN	B
before	O	ADP	O
RAI	O	NOUN	B
vs.	O	CCONJ	O
the	O	DET	O
shorter	O	ADJ	B
period	O	NOUN	B
in	O	ADP	O
patients	O	NOUN	B
before	O	ADP	O
surgery	O	NOUN	B
.	O	PUNCT	O


Its	O	PRON	O
mRNA	O	NOUN	B
expression	O	NOUN	O
pattern	O	NOUN	O
is	O	AUX	O
complex	O	ADJ	B
during	O	ADP	O
embryogenesis	O	NOUN	B
,	O	PUNCT	O
yet	O	ADV	O
restricted	O	ADJ	O
to	O	PART	O
lymphocytes	B-cell_type	NOUN	B
postnatally	O	ADV	B
.	O	PUNCT	O


Growth	O	NOUN	B
regulation	O	NOUN	I
and	O	CCONJ	O
cellular	O	ADJ	B
changes	O	NOUN	I
during	O	ADP	O
differentiation	O	NOUN	B
of	O	ADP	O
human	B-cell_line	ADJ	B
prostatic	I-cell_line	ADJ	O
cancer	I-cell_line	NOUN	O
LNCaP	I-cell_line	NOUN	B
cells	I-cell_line	NOUN	I
as	O	ADP	O
induced	O	VERB	B
by	O	ADP	O
T	O	NOUN	B
lymphocyte-conditioned	O	ADJ	I
medium	O	NOUN	I
.	O	PUNCT	O


